Targeting Endothelial Connexin37 Reduces Angiogenesis and Decreases Tumor Growth

• Published in: International journal of molecular sciences 2022-03, Vol.23 (6), p.2930
• Main Authors: Sathiyanadan, Karthik, Alonso, Florian, Domingos-Pereira, Sonia, Santoro, Tania, Hamard, Lauriane, Cesson, Valérie, Meda, Paolo, Nardelli-Haefliger, Denise, Haefliger, Jacques-Antoine
• Format: Article
• Language: English
• Subjects: Angiogenesis; Animals; Bladder; Blood vessels; Cell Proliferation; cell-cell communication; Channels; connexins; Connexins - genetics; Endothelial cells; Endothelial Cells - physiology; Endothelium, Vascular - pathology; Hemoglobin; Hypoxia; Mice; Neoplasms - drug therapy; Neoplasms - pathology; Neovascularization, Pathologic - drug therapy; Neovascularization, Pathologic - pathology; Peptides; Perfusion; Permeability; Plugs; Rodents; transgenic mice; Tumors; Vascular endothelial growth factor; Vascularization
• ISSN: 1422-0067; 1661-6596; 1422-0067
• DOI: 10.3390/ijms23062930

Connexin37 (Cx37) and Cx40 form intercellular channels between endothelial cells (EC), which contribute to the regulation of the functions of vessels. We previously documented the participation of both Cx in developmental angiogenesis and have further shown that loss of Cx40 decreases the growth of different tumors. Here, we report that loss of Cx37 reduces (1) the in vitro proliferation of primary human EC; (2) the vascularization of subcutaneously implanted matrigel plugs in Cx37-/- mice or in WT using matrigel plugs supplemented with a peptide targeting Cx37 channels; (3) tumor angiogenesis; and (4) the growth of TC-1 and B16 tumors, resulting in a longer mice survival. We further document that Cx37 and Cx40 function in a collaborative manner to promote tumor growth, inasmuch as the injection of a peptide targeting Cx40 into Cx37-/- mice decreased the growth of TC-1 tumors to a larger extent than after loss of Cx37. This loss did not alter vessel perfusion, mural cells coverage and tumor hypoxia compared to tumors grown in WT mice. The data show that Cx37 is relevant for the control of EC proliferation and growth in different tumor models, suggesting that it may be a target, alone or in combination with Cx40, in the development of anti-tumoral treatments.